Product NewsDrug discovery > Drug Manufacturing
Advancing lab access to lyophilized bead technology
25 Feb 2025
Cameron Smith-Craig
Pharma and Applied Sciences Editor
Hear from Brian Kirk, VP of Product Development, as he discusses BioDot’s mission and the growing role of microfluidics in the lab. Learn why lyophilized beads are gaining traction in diagnostics and pharma, and how the Sphera™ Discovery is set to bring lyobead production from larger manufacturing into the lab. Kirk also shares his vision for the future impact of lyobead technology on these industries.
This video was filmed at SLAS 2025.
Related Products
Request Quote for All Products
Sphera™
BioDot Inc.Discrete Droplet Dispensing™, ONLY cooler! Unleash the power of discrete droplet dispensing to enable superior performance. Better Yield. Higher Throughput. Expanded Dynamic Range. BioDot’s platform design expertise applied to the Lyobead formation challenge in an established product.
